Fox Chase Cancer Center Welcomes Andres F. Correa

PHILADELPHIA (April 14, 2020) – Fox Chase Cancer Center announces the hiring of Andres F. Correa, MD, who will join the department of surgery in the Urologic Oncology Division. Correa will be an assistant professor in the academic clinician track.

Correa, who was a Society of Urologic Oncology Fellow at Fox Chase, is returning to the center after serving as attending surgeon and assistant professor in the division of urology in the department of surgery at MD Anderson Cancer Center at Cooper University Hospital.

He received his medical degree from the University of Maryland School of Medicine, where he graduated magna cum laude. Correa was a general surgery intern at the University of Pittsburgh Medical Center before becoming a urology resident and eventually the urology chief resident.

Correa is skilled at all surgical modalities including robotics, laparoscopy, and traditional open surgery, and has deep expertise in prostate, kidney, bladder, testicular, and other genitourinary cancers. 

“Fox Chase Urologic Oncology is extremely fortunate to recruit talent of such high caliber. Dr. Correa is a second-to-none academic clinician who unites clinical wisdom, superb surgical skill, and an unparalleled knowledge base with superlative communication skills, sincere compassion, and an utmost sense of duty,” said Alexander Kutikov, MD, chief of the Urologic Oncology Division.

Correa is a member of the American Medical Association, National Hispanic Medical Association, American Urological Association, and the Society of Urologic Oncology.

He has published over 20 manuscripts in peer-reviewed journals—including seminal work on prediction of kidney cancer recurrence in the prestigious Journal of Clinical Oncology—has presented at numerous academic meetings, and contributed to book chapters in the field of urologic oncology.  

Correa is fluent in Spanish and has received the honor of being nominated as a top doctor in the Philadelphia area by Al Día News Media.

Correa will begin work at Fox Chase on May 4, 2020.

To Schedule an Appointment, Contact the GU Navigators

Peggy McGinn, BSN, RN, OCN
215-728-5503
[email protected]

Trish O’Brien, BSN, RN
215-214-3988
[email protected]    

Monica Scanlan, BSN, RN
215-214-1773
[email protected]

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text